Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Argonde C van Harten

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Neurobiology of Aging|April 29, 2019
ApoE and clusterin CSF levels influence associations between APOE genotype and changes in CSF tau, but not CSF Aβ42, levels in non-demented elderlyRosalinde E R Slot, Maartje I Kester, Argonde C Van Harten, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsFloor Duits, Paula I Vanneste, Niki S M Schoonenboom, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 12, 2025
"Real-world" eligibility for anti-amyloid treatment in a tertiary memory clinic settingSinthujah Vigneswaran, Everard G B Vijverberg, Frederik Barkhof, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersCalvin Trieu, Ellen Dicks, Mardou S S A van Leeuwenstijn, et al.
Neurology|July 1, 2018
Subjective cognitive decline and risk of MCI: The Mayo Clinic Study of AgingArgonde C van Harten, Michelle M Mielke, Dana M Swenson-Dravis, et al.
Neurology|January 25, 2022
Association of the ATN Research Framework With Clinical Profile, Cognitive Decline, and Mortality in Patients With Dementia With Lewy BodiesMarleen van de Beek, Floor A H Ooms, Jarith L Ebenau, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 24, 2021
P-tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET statusMichelle R Campbell, Susan Ashrafzadeh-Kian, Ronald C Petersen, et al.
Journal of Alzheimer'S Disease : JAD|March 30, 2026
The ABOARD-RWD infrastructure: Using linked real-world data to study the diagnosis and management of dementiaBrenda N Baak, Casper de Boer, Mahsa Nooralishahi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthSinthujah Vigneswaran, Everard G B Vijverberg, Frederik Barkhof, et al.
JAMA Neurology|November 13, 2018
Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive ImpairmentSilke Kern, Jeremy A Syrjanen, Kaj Blennow, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Neurobiology of Aging|April 29, 2019
ApoE and clusterin CSF levels influence associations between APOE genotype and changes in CSF tau, but not CSF Aβ42, levels in non-demented elderlyRosalinde E R Slot, Maartje I Kester, Argonde C Van Harten, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsFloor Duits, Paula I Vanneste, Niki S M Schoonenboom, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 12, 2025
"Real-world" eligibility for anti-amyloid treatment in a tertiary memory clinic settingSinthujah Vigneswaran, Everard G B Vijverberg, Frederik Barkhof, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersCalvin Trieu, Ellen Dicks, Mardou S S A van Leeuwenstijn, et al.
Neurology|July 1, 2018
Subjective cognitive decline and risk of MCI: The Mayo Clinic Study of AgingArgonde C van Harten, Michelle M Mielke, Dana M Swenson-Dravis, et al.
Neurology|January 25, 2022
Association of the ATN Research Framework With Clinical Profile, Cognitive Decline, and Mortality in Patients With Dementia With Lewy BodiesMarleen van de Beek, Floor A H Ooms, Jarith L Ebenau, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 24, 2021
P-tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET statusMichelle R Campbell, Susan Ashrafzadeh-Kian, Ronald C Petersen, et al.
Journal of Alzheimer'S Disease : JAD|March 30, 2026
The ABOARD-RWD infrastructure: Using linked real-world data to study the diagnosis and management of dementiaBrenda N Baak, Casper de Boer, Mahsa Nooralishahi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthSinthujah Vigneswaran, Everard G B Vijverberg, Frederik Barkhof, et al.
JAMA Neurology|November 13, 2018
Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive ImpairmentSilke Kern, Jeremy A Syrjanen, Kaj Blennow, et al.
Pageof 8